Other healthcare companies such as Daiichi Sankyo have also announced investments in Germany recently, in a positive sign for the ruling coalition government. ADVERTISEMENT French pharmaceutical giant Sanofi could potentially invest somewhere between €1.3 billion and €1.5 billion in its Frankfurt manufacturing site making the insulin brand, Lantus, according to German newspaper Handelsblatt and Reuters.